[Congressional Record Volume 169, Number 200 (Tuesday, December 5, 2023)]
[Senate]
[Page S5744]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                         MESSAGE FROM THE HOUSE

  At 12:31 p.m., a message from the House of Representatives, delivered 
by Mrs. Cole, one of its reading clerks, announced that the House has 
passed the following bills, in which it requests the concurrence of the 
Senate:

       H.R. 1713. An act to provide for Department of Energy and 
     Department of Agriculture joint research and development 
     activities, and for other purposes.
       H.R. 2980. An act to provide for Department of Energy and 
     National Science Foundation research and development 
     coordination, and for other purposes.
       H.R. 2988. An act to provide for Department of Energy and 
     National Aeronautics and Space Administration research and 
     development coordination, and for other purposes.
       H.R. 3581. An act to amend title 38, United States Code, to 
     modify the family caregiver program of the Department of 
     Veterans Affairs to include services related to mental health 
     and neurological disorders, and for other purposes.
       H.R. 4688. An act to direct the Administrator of General 
     Services to sell the property known as Webster School.

  The message also announced that the House has passed the following 
bill, with amendment, in which it requests the concurrence of the 
Senate:

       S. 992. An act to amend the Intermodal Surface 
     Transportation Efficiency Act of 1991 to designate the Texas 
     and New Mexico portions of the future Interstate-designated 
     segments of the Port-to-Plains Corridor as Interstate Route 
     27, and for other purposes.

  The message further announced that the House agrees to the amendment 
of the Senate to the bill (H.R. 1734) to require coordinated National 
Institute of Standards and Technology science and research activities 
regarding illicit drugs containing xylazine, novel synthetic opioids, 
and other substances of concern, and for other purposes.

                          ____________________